These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1246049)

  • 1. Catechol O-methyltransferase. 7. Affinity labeling with the oxidation products of 6-aminodopamine.
    Borchardt RT; Smissman EE; Nerland D; Reid JR
    J Med Chem; 1976 Jan; 19(1):30-7. PubMed ID: 1246049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol O-methyltransferase. 12. Affinity labeling the active site with the oxidation products of 5,6-dihydroxyindole.
    Borchardt RT; Bhatia P
    J Med Chem; 1982 Mar; 25(3):263-71. PubMed ID: 7069705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol O-methyltransferase. 9. Mechanism of inactivation by 6-hydroxydopamine.
    Borchardt RT; Reid JR; Thakker DR
    J Med Chem; 1976 Oct; 19(10):1201-9. PubMed ID: 994150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol O-methyltransferase. 6. Affinity labeling with N-haloacetyl-3,5-dimethoxy-4-hydroxyphenylalkylamines.
    Borchardt RT; Thakker DR
    J Med Chem; 1975 Feb; 18(2):152-8. PubMed ID: 1120981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol O-methyltransferase activity in the human placenta and liver.
    Burba JV
    Can J Physiol Pharmacol; 1979 Feb; 57(2):213-6. PubMed ID: 546488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity labeling of catechol O-methyltransferase by N-haloacetyl derivatives of 3,5-dimethoxy-4-hydroxyphenylethylamine and 3,4-dimethoxy-5-hydroxyphenylethylamine. Kinetics of inactivation.
    Borchardt RT; Thakker DR
    Biochemistry; 1975 Oct; 14(20):4543-51. PubMed ID: 240407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of catechol-O-methyltransferase by 6,7-dihydroxy-3,4-dihydroisoquinolines related to dopamine: demonstration using liquid chromatography and a novel substrate for O-methylation.
    Cheng BY; Origitano TC; Collins MA
    J Neurochem; 1987 Mar; 48(3):779-86. PubMed ID: 2433397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity.
    Li SA; Purdy RH; Li JJ
    Carcinogenesis; 1989 Jan; 10(1):63-7. PubMed ID: 2910532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of rat brain and liver solubilized membrane-bound catechol-O-methyltransferase.
    Bonifácio MJ; Vieira-Coelho MA; Borges N; Soares-da-Silva P
    Arch Biochem Biophys; 2000 Dec; 384(2):361-7. PubMed ID: 11368324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites.
    Liang SC; Ge GB; Xia YL; Pei-Pei D; Ping W; Qi XY; Cai-Xia T; Ling Y
    Xenobiotica; 2017 Jun; 47(6):498-504. PubMed ID: 27435571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of dopamine, NN-dialkylated dopamines and derivatives of the dopamine agonist 2-amino-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) by catechol-O-methyltransferase.
    Youde IR; Raxworthy MJ; Gulliver PA; Dijkstra D; Horn AS
    J Pharm Pharmacol; 1984 May; 36(5):309-13. PubMed ID: 6145766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line.
    Malherbe P; Bertocci B; Caspers P; Zürcher G; Da Prada M
    J Neurochem; 1992 May; 58(5):1782-9. PubMed ID: 1560233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
    Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
    Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization and partial purification of particulate catechol-O-methyltransferase from rat liver.
    Tong JH; D'Iorio A
    Can J Biochem; 1977 Oct; 55(10):1108-13. PubMed ID: 912603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoaffinity labeling of catechol O-methyltransferase with 8-azido-S-adenosylmethionine.
    Kaiser II; Kladianos DM; Van Kirk EA; Haley BE
    J Biol Chem; 1983 Feb; 258(3):1747-51. PubMed ID: 6337144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection.
    Nissinen E; Männistö P
    Anal Biochem; 1984 Feb; 137(1):69-73. PubMed ID: 6731809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
    Butterworth M; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase.
    Rivett AJ; Roth JA
    Biochemistry; 1982 Apr; 21(8):1740-2. PubMed ID: 7082642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.